LIUZZI, Grazia Maria
 Distribuzione geografica
Continente #
NA - Nord America 6.567
AS - Asia 2.574
EU - Europa 1.969
SA - Sud America 613
AF - Africa 160
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 2
Totale 11.892
Nazione #
US - Stati Uniti d'America 6.487
SG - Singapore 1.136
CN - Cina 744
BR - Brasile 546
HK - Hong Kong 390
SE - Svezia 387
IT - Italia 310
RU - Federazione Russa 251
UA - Ucraina 248
DE - Germania 244
FI - Finlandia 159
FR - Francia 122
CI - Costa d'Avorio 118
GB - Regno Unito 100
VN - Vietnam 100
IN - India 52
CA - Canada 45
AR - Argentina 27
BE - Belgio 26
BD - Bangladesh 23
NL - Olanda 22
IE - Irlanda 21
MX - Messico 20
ZA - Sudafrica 20
PL - Polonia 17
JP - Giappone 16
ID - Indonesia 14
IQ - Iraq 14
TR - Turchia 14
ES - Italia 13
AT - Austria 11
VE - Venezuela 11
IR - Iran 10
CZ - Repubblica Ceca 8
AU - Australia 7
LT - Lituania 7
PK - Pakistan 7
SA - Arabia Saudita 7
AE - Emirati Arabi Uniti 6
EC - Ecuador 6
CO - Colombia 5
JO - Giordania 5
MA - Marocco 5
MY - Malesia 5
PY - Paraguay 5
TN - Tunisia 5
UZ - Uzbekistan 5
AZ - Azerbaigian 4
HN - Honduras 4
LB - Libano 4
PE - Perù 4
AL - Albania 3
CL - Cile 3
CR - Costa Rica 3
DZ - Algeria 3
OM - Oman 3
PT - Portogallo 3
RS - Serbia 3
UY - Uruguay 3
BH - Bahrain 2
BO - Bolivia 2
EG - Egitto 2
ET - Etiopia 2
HU - Ungheria 2
IL - Israele 2
JM - Giamaica 2
KR - Corea 2
NP - Nepal 2
SI - Slovenia 2
TT - Trinidad e Tobago 2
AO - Angola 1
BG - Bulgaria 1
BY - Bielorussia 1
BZ - Belize 1
CH - Svizzera 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EU - Europa 1
GE - Georgia 1
GR - Grecia 1
GY - Guiana 1
KE - Kenya 1
KZ - Kazakistan 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
MK - Macedonia 1
MN - Mongolia 1
MW - Malawi 1
MZ - Mozambico 1
NI - Nicaragua 1
PA - Panama 1
PH - Filippine 1
PS - Palestinian Territory 1
QA - Qatar 1
RO - Romania 1
SY - Repubblica araba siriana 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 11.892
Città #
Woodbridge 672
Fairfield 605
Chandler 604
Jacksonville 563
Ashburn 559
Singapore 523
Houston 410
Hong Kong 389
Ann Arbor 333
Nyköping 315
Wilmington 245
Seattle 241
Cambridge 227
Beijing 217
Lawrence 127
Roxbury 126
Abidjan 118
Nanjing 110
Marseille 97
New York 90
Bari 88
Boardman 84
Des Moines 79
Los Angeles 62
Inglewood 56
Dallas 51
São Paulo 49
Munich 43
Ho Chi Minh City 39
Princeton 39
Jiaxing 37
Santa Clara 36
Brooklyn 35
Shenyang 34
Buffalo 29
Nanchang 29
Turku 28
Moscow 27
San Diego 27
Brussels 25
Changsha 25
Guangzhou 25
Hebei 24
Hanoi 22
Dublin 21
Shanghai 21
London 19
Belo Horizonte 18
Chicago 18
Denver 18
Tianjin 17
Leawood 16
Leverano 16
Amsterdam 15
Dearborn 15
Rio de Janeiro 15
San Francisco 15
Spongano 15
Toronto 15
Warsaw 15
Dhaka 14
Wuhan 14
Auburn Hills 13
Jakarta 13
Tokyo 13
Curitiba 12
Monmouth Junction 12
Rome 12
Falkenstein 11
Falls Church 11
Augusta 10
Chennai 10
Helsinki 10
Atlanta 9
Campinas 9
Frankfurt am Main 9
Grottaglie 9
Mumbai 9
Norwalk 9
Paris 9
Porto Alegre 9
Pune 9
Salvador 9
Stockholm 9
Zhengzhou 9
Boston 8
Jinan 8
Johannesburg 8
Montreal 8
Nuremberg 8
Ardabil 7
Council Bluffs 7
Hefei 7
Kunming 7
Milan 7
Osasco 7
Palermo 7
Vienna 7
Washington 7
Baghdad 6
Totale 8.205
Nome #
Inhibitory Effect of Aqueous Extracts from Marine Sponges on the Activity and Expression of Gelatinases A (MMP-2) and B (MMP-9) in Rat Astrocyte Cultures 166
Cytotoxicity Study on Luminescent Nanocrystals Containing Phospholipid Micelles in Primary Cultures of Rat Astrocytes 163
Adhesion molecules and matrix metalloproteinases in Multiple Sclerosis: effects induced by Interferon-beta 157
Comparative analysis of protein profiles of aqueous extracts from marine sponges and assessment of cytotoxicity on different mammalian cell types 148
FAD synthesis and degradation in the nucleus create a local flavin cofactor pool 142
Biological variations in a long-term ex situ cultivation: a Mediterranean demosponge as model system 135
A thermodynamic and structural study of myelin basic protein in lipid membrane models 134
Apolipoprotein(a) inhibits lipopolysaccharide-induced IL-6 secretion in human astrocytoma cell line by interfering with lipopolysaccharide signaling 130
A monoclonal antibody inhibits gelatinase B/MMP-9 by selective binding to part of the catalytic domain and not to the fibronectin or zinc binding domains 127
Antiretroviral Treatment Modulates The Release Of Matrix Metalloproteinases In Rat Astrocyte Cell Cultures 126
Liver fibrosis in HCV monoinfected and HIV/HCV coinfected patients: Dysregulation of matrix metalloproteinases (MMPs) and their tissue inhibitors TIMPs and effect of HCV protease inhibitors 126
Autoimmune Myelofibrosis: report of three cases and review of the literature 121
BLOOD MMP-9 AND SICAM-1 AS MARKERS OF RIFN-B TREATMENT EFFICACY IN RELAPSING-REMITTING MS 118
Native Myelin Proteins and Myelin Assembly in the Central Nervous System 117
Aquaporin-4-containing astrocytes sustain a temperature- and mercury-insensitive swelling in vitro 117
Structure-Dependent Inhibition of Gelatinases by Dietary Antioxidants in Rat Astrocytes and Sera of Multiple Sclerosis Patients 115
Antibodies specific for the lipid-bound form of myelin basic protein during experimental autoimmune encephalomyelitis 115
Antiretroviral treatment modulates the release of matrix metalloproteinases in rat astrocyte cell cultures 113
Matrix metalloproteinase dysregulation in HIV infection: implications for therapeutic strategies 113
Antiretroviral therapy inhibits matrix metalloproteinase-9 from blood mononuclear cells of HIV-infected patients 113
In Vitro Downregulation of Matrix Metalloproteinase-9 in Rat Glial Cells by CCR5 Antagonist Maraviroc: Therapeutic Implication for HIV Brain Infection. 112
Identification of water-soluble proteases in myelin preparations 111
Myelin degrading activity in the CSF of HIV-1-infected patients with neurological diseases 111
Cerebrospinal fluid myelin basic protein as predictive marker of demyelination in AIDS dementia complex 111
Anti-endothelial cell antibodies (AECA) in a patient wiyh Takayasu’s arteritis. In: Pathogenesis and immunotherapy of autoimmune diseases. Final program and abstract book 109
Serum MMP-2 and MMP-9 are elevated in different multiple sclerosis subtypes 109
T-cell response to myelin basic protein and lipid-bound myelin basic protein in patients with multiple sclerosis and healthy donors 108
Coordinated inhibition of Matrix Metalloproteinase-9 and Urokinase Plasminogen activator by immunomodulant therapies in peripheral blood Mononuclear Cells from MS patients 107
Recombinant arabidopsis HSP70 sustains cell survival and metastatic potential of breast cancer cells 107
New Diagnostic and Therapeutic Options for the Treatment of Multiple Sclerosis 106
Expression of myelin basic protein (MBP) epitopes in human non-neural cells revealed by two anti-MBP IgM monoclonal antibodies 106
Marine pharmacology: Therapeutic targeting of matrix metalloproteinases in neuroinflammation 106
FAD synthase deficiency: a severe mitochondrial myopathy searching for novel therapeutic strategies 106
Different recognition by clostripain of myelin basic protein in the lipid-free and lipid-bound forms 104
In vitro effect of antiretroviral drugs on cultured primary astrocytes: analysis of neurotoxicity and matrix metalloproteinase inhibition 102
Crystals of P2 myelin protein in lipid-bound form 101
May diet and dietary supplements improve the wellness of multiple sclerosis patients? A molecular approach. 100
Detection of cerebrospinal fluid antibodies against myelin basic protein in patients with AIDS dementia complex 100
Dysregulation of MMPs and TIMPs in HCV in monoinfected and HCV/HIV coinfected patients. Positive effect of HCV protease inhibitor treatment. 99
Heterogeneity of serum gelatinases MMP-2 and MMP-9 isoforms and charge variants. 98
Aids dementia complex. On the relationship between HIV-1 infection, immune-mediated response and myelin damage in the brain 97
Purification of bovine P2 myelin protein with bound lipids 97
Regulation of gelatinases in microglia and astrocyte cell cultures by plant lectins 96
ADHESION MOLECULES AND MATRIX METALLOPROTEINASES IN MS: EFFECTS INDUCED BY INTERFERON BETA 95
FAD synthase deficiency: a severe mitochondrial myopathy involving a secondary reduction of RFVT2 expression 93
Lipoprotein(a) in the cerebrospinal fluid of neurological patients with blood-cerebrospinal fluid barrier dysfunction 92
Neuroprotective effect of resveratrol egainst Manganese-induced Matrix Matalloproteinases-9 and oxidative stress in a “vivo” model of neurotoxicity. 91
The different forms of PNS myelin P0 protein within and outside lipid rafts 91
null 91
null 90
Inhibition of aquaporin-4 expression in astrocytes by RNAi determines alteration in cell morphology, growth, and water transport and induces changes in ischemia-related genes 90
INTERFERON-beta INHIBITS THE EXPRESSION OF METALLOPROTEINASES IN RAT GLIAL CELL CULTURES: IMPLICATIONS FOR MULTIPLE SCLEROSIS PATHOGENESIS AND TREATMENT 89
Lipoprotein(a) presence in the cerebrospinal fluid of patients with neurologic disorders 88
CHANGES OF SERUM ICAM-1 AND MMP-9 INDUCED BY RIFNB-1B TREATMENT IN RELAPSING-REMITTING MS 88
null 87
Autoimmune bone marrow fibrosis: a distinct clinicopathological entity 86
Assessment of cell toxicity and matrix metalloproteinase-9 expression by antiretroviral drugs in cultured primary astrocytes. 86
Laminar order within Langmuir-Blodgett multilayers from phospholipid and myelin basic protein: a neutron reflectivity study 85
Impact of lead neurotoxicity on gelatinase production in THP-1 cells. effects of antioxidants and therapeutical implication for the treatment of cns diseases 84
Luminescent Polymeric Nanovectors Loaded with Darunavir for Treatment of HIV-Associated Neurological Diseases 84
Detection of MMP-9 sialylated isotypes in sera of patients with relapsing/remitting multiple sclerosis 83
Meccanismo molecolare di “Swelling” in astrociti in coltura 83
Detection of serum levels and intrathecal synthesis of matrix metallo proteinase-9 in relapsing-remitting multiple sclerosis 82
Ruolo delle proteasi nell’induzione e nella patogenesi della sclerosi multipla 82
Decreased levels of serum Gelatinase B in MS patients treated with rIFN-beta-1b 82
Intrathecal synthesis of matrix metalloproteinase-9 in patients with multiple sclerosis: implication for pathogenesis 82
Retrograde response to mitochondrial dysfunctions associated to LOF variations in FLAD1 exon 2: unraveling the importance of RFVT2 81
In vitro effect of antiretroviral drugs on cell toxicity and matrix metalloproteinase-9 inhibition in cultured primary astrocytes. 81
Aumento dell’attività della Gelatinasi B nel liquor di pazienti HIV-positivi con malattie neurologiche del Sistema Nervoso Centrale 81
Induction of experimental autoimmune encephalomyelitis in rats and immune response to myelin basic protein in lipid-bound form 80
Inhibitory Effect of Polyunsaturated Fatty Acids on MMP-9 Release from Microglial Cells-Implications for Complementary Multiple Sclerosis Treatment 80
Luminescent PLGA Nanoparticles for Delivery of Darunavir to the Brain and Inhibition of Matrix Metalloproteinase-9, a Relevant Therapeutic Target of HIV-Associated Neurological Disorders 79
Increased Gelatinase B Activity in the CSF of Patients with HIV-Associated Neurological Diseases 78
Determinazione degli Anticorpi Liquorali Anti-MBP per la Diagnosi di Danno Mielinico in Pazienti con AIDS Dementia Complex 77
Meccanismi di demielinizzazione in pazienti con neuroAIDS 77
CEREBROSPINAL FLUID MARKERS FOR THE MONITORING OF AIDS DEMENTIA COMPLEX SEVERITY: USEFULNESS OF ANTI-MYELIN BASIC PROTEIN ANTIBODY DETECTION 77
Release of myelin basic protein-degrading proteolytic activity from microglia and macrophages after infection with Theiler's murine encephalomyelitis virus: comparison between susceptible and resistant mice 77
Dynamic changes of MMP-9 plasma levels correlate with JCV reactivation and immune activation in natalizumab-treated multiple sclerosis patients 77
Bioisosteric replacement based on 1,2,4-oxadiazoles in the discovery of 1H-indazole-bearing neuroprotective MAO B inhibitors 76
In vitro downregulation of matrix metalloproteinase-9 in rat astrocytes by CCR5 antagonist maraviroc: potential therapeutical implication for HIV-associated neurological disease. 76
Interferon-beta Treatment Inhibits Calpain Expression In Rat Astrocytes. Implications For Ms Pathogenesis And Treatment. 76
Demyelination and cerebral toxoplasmosis in HIV-infected patients 75
Bioassay-guided identification of bioactive protein compounds from the Mediterranean demosponge Tethya meloni 75
CNS Myelin Proteins in Lipid-Bound Native Form as Tools for Study, Detection and Treatment of Multiple Sclerosis 74
Intrathecal synthesis of matrix metalloproteinase (MMP)-9 in patients with relapsing-remitting (RR) multiple sclerosis (MS) 73
Regulation of gelatinases in microglia and astrocyte cell cultures by plant lectins 73
Matrix metalloproteinases in demyelinating diseases: targets for treatment. 72
CHANGES OF SERUM SOLUBLE ICAM-1 AND MATRIX METALLOPROTEINASE-9 DURING INTERFERON BETA-1B TREATMENT IN RR MS 72
Il ruolo delle proteasi nell’induzione e nella patogenesi della Sclerosi Multipla 72
Follow-up of myelin damage in HIV-associated cryptococcal meningitis. First evidence of anti-myelin basic protein antibodies in the cerebrospinal fluid 71
Inhibition of myelin-cleaving proteolytic activities by interferon-beta in rat astrocyte cultures. Comparative analysis between gelatinases and calpain-II. 71
Matrix Metalloproteinases in CNS Inflammation. 70
Oral administration of nucleotides in calves: Effects on oxidative status, immune response, and intestinal mucosa development 70
Anti-HIV drugs decrease the expression of matrix metalloproteinases in astrocytes and microglia 69
Matrix metalloproteinase-9 and tissue inhibitors of matrix metalloproteinase-1 in plasma of patients co-infected with HCV and HIV 69
Impact of manganese neurotoxicity on gelatinase production in rat primary astrocytes. Effect of resveratrol and therapeutical implications for the treatment of CNS diseases. 69
Plant Lectins Regulate the Release of Matrix Metalloproteases in Rat Glial Cell Cultures 69
Extracting and purifying R-phycoerythrin from Mediterranean red algae Corallina elongata Ellis & Solander 69
Decreased levels of serum gelatinase B in MS patients during the treatment with rIFN-beta-1b 68
In vitro cell toxicity and Matrix Metalloproteinase-9 inhibition by antiretroviral drugs in cultured primary astrocytes 67
Totale 9.524
Categoria #
all - tutte 49.716
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.716


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021629 0 0 0 0 0 36 103 67 112 154 121 36
2021/2022805 24 116 6 24 33 51 32 47 57 55 158 202
2022/20231.675 197 138 106 170 216 213 13 187 347 36 25 27
2023/2024551 44 97 23 120 46 118 7 6 6 14 10 60
2024/20252.239 130 41 197 60 66 134 183 181 96 104 297 750
2025/20262.292 678 269 300 493 515 37 0 0 0 0 0 0
Totale 12.079